Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 4Phase 2/3 3Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Carcinoma 3Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Gallbladder Neoplasms 1Extensive Stage Small Cell Lung Carcinoma 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Advanced Glioblastoma 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3Radiotherapy 2Radiation 2Platinum 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2(225)Ac-DOTA-c(RGDyK) 2menatetrenone 1durvalumab 1atezolizumab 1Surgical Procedures, Operative 1Specimen Handling 1Photochemotherapy 1Neck Dissection 1Irinotecan 1Gemcitabine 1Endoscopy 1Docetaxel 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT03258554 2026-02-06

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

University of California, San Diego

Phase 2/3 Completed
101 enrolled 13 charts
Gynecologic

Carcinoma, Uterine Cervical Neoplasms

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡